Faruqi & Faruqi, LLP Announces Investigation Related to the Acquisition of Cellu Tissue Holdings, Inc.

Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Cellu Tissue Holdings, Inc. (“Cellu Holdings” or the “Company”) (NYSE: CLU) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to Clearwater Paper Corporation (NYSE: CLW). The proposed transaction offers Cellu Holdings shareholders to only receive $12.00 in cash for each share they own. According to Thomson/First Call, at least one financial analyst values Cellu Holdings’ common stock at $16.00 per share.

Whether the Cellu Holdings’ Board of Directors breached their fiduciary duties to Cellu Holdings’ stockholders by failing to conduct an adequate and fair sales process to sell the Company prior to agreeing to this proposed transaction, whether the proposed transaction undervalues Cellu Holdings shares and by how much this proposed transaction undervalues the Company to the detriment of Cellu Holdings shareholders are the key focus of this investigation.

Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, through all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm’s clients.

If you own common stock in Cellu Holdings and wish to obtain additional information, please visit us at www.faruqilaw.com/celluholdings or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@faruqilaw.com or by telephone at (877) 247-4292 or (212) 983-9330.

Attorney Advertising. (C) 2010 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We are happy to discuss your particular case.

Canada Life (NYSE:CLU)
過去株価チャート
から 3 2025 まで 4 2025